Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
22.02
+0.23 (1.03%)
Nov 21, 2024, 3:17 PM EST - Market open

Company Description

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally.

The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products.

In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services.

The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents.

Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG
Fresenius Medical Care AG logo
Country Germany
Founded 1996
IPO Date Sep 19, 1996
Industry Medical Care Facilities
Sector Healthcare
Employees 119,845
CEO Helen Giza

Contact Details

Address:
Else-KrOener-Strasse 1
Bad Homburg, 61352
Germany
Phone 49 6172 609 0
Website freseniusmedicalcare.com

Stock Details

Ticker Symbol FMS
Exchange NYSE
Fiscal Year January - December
Reporting Currency EUR
CIK Code 0001333141
CUSIP Number 358029106
ISIN Number US3580291066
SIC Code 8090

Key Executives

Name Position
Craig Cordola FACHE, M.B.A., M.H.A. Chief Executive Officer of Care Delivery and Member of Management Board
Dr. Katarzyna Mazur-Hofsab Ph.D. Chief Executive Officer of Care Enablement and Member of Management Board
Helen Giza Chair of Management Board and Chief Executive Officer
Martin Fischer Chief Financial Officer and Member of the Management Board
Dr. Franklin W. Maddux F.A.C.P. Global Chief Medical Officer and Member of Management Board
Dr. Dominik Heger Executive Vice President and Head of Investor Relations, Strategic Development and Communications
Jorg Haring Global Head of Legal, Compliance and Human Resources and Labor Director
Joachim Weith Senior Vice President of Corporate Communications and Governmental Affairs
Dr. Gail-Suzanne Brown Senior Vice President of Research and Development
Glenn Slater Senior Vice President of Manufacturing and Supply Chain Operations

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 5, 2024 6-K Report of foreign issuer
Nov 5, 2024 6-K Report of foreign issuer
Jul 30, 2024 6-K Report of foreign issuer
Jul 30, 2024 6-K Report of foreign issuer
Jun 28, 2024 11-K Annual report of employee stock purchase, savings and similar plans
May 28, 2024 SD Form - SD
May 23, 2024 6-K Report of foreign issuer
May 16, 2024 6-K Report of foreign issuer
May 7, 2024 6-K Report of foreign issuer